Amphiphilic Carbohydrate Polymers Hierarchical Micellar Clusters
Solution Overview
Problem
Current methods for formulating drugs with poor aqueous solubility, such as hydrophobic drugs, face challenges in achieving sufficient bioavailability due to inefficient solubilization and stability issues in micellar systems, often requiring high molar ratios of amphiphilic compounds to drugs and resulting in limited bioavailability across biological barriers.
Innovation Solution
The development of amphiphilic carbohydrate polymers that self-assemble into hierarchically organized micellar clusters, which transform into stable nanoparticles, allowing for higher molar polymer/drug ratios and enhanced drug encapsulation and transfer across biological barriers, particularly for hydrophobic drugs with poor aqueous solubility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional block copolymers are used to solubilize hydrophobic drugs, then micellar structures are formed, but the molar amphiphile/drug ratios are excessively high (exceeding 10:1 and frequently extending to 1000:1) resulting in inefficient drug carrying capacity
Solution Approach 1:
The invention divides the micellar structure into hierarchical levels: individual micelles self-assemble from amphiphilic block copolymer chains, and these micelles further aggregate to form micellar clusters. This segmentation creates a multi-level organization where the hydrophobic core volume is dramatically increased through cluster formation, enabling much higher drug carrying capacity without proportionally increasing the amphiphile/drug ratio
Solution Approach 2:
The invention merges multiple individual micelles into larger micellar clusters through controlled aggregation. By combining the hydrophobic cores of multiple micelles while maintaining their individual structural integrity, the system creates a larger effective hydrophobic volume that can accommodate more drug molecules, thereby improving drug carrying capacity while reducing the required amphiphile/drug ratio
2Quantity of substance
If the aggregation number of monomers is increased to yield larger particles and increase hydrophobic volume, then drug solubilization capacity is improved, but excessive aggregation leads to precipitation of the colloid forming molecules and the drug
Solution Approach 1:
The invention segments the aggregation process into two distinct levels: first, individual micelles form with controlled aggregation numbers; second, these micelles aggregate into clusters. This segmentation allows the system to achieve large effective hydrophobic volume for drug solubilization while maintaining the stability of individual micellar units, preventing the uncontrolled aggregation that would lead to precipitation
Solution Approach 2:
The invention introduces dynamic control over the aggregation process through parameters such as amphiphile concentration, temperature, and solvent conditions. By controlling the degree of micelle-micelle aggregation, the system can optimize the balance between achieving sufficient hydrophobic volume for drug solubilization and maintaining colloid stability to prevent precipitation
3Quantity of substance
If conventional micellar systems are used for hydrophobic drugs, then some solubilization is achieved, but bioavailability across biological barriers remains limited
Solution Approach 1:
The invention transitions from conventional single-level micellar structures to a hierarchical two-level structure where micelles aggregate into clusters. This dimensional change in structural organization creates a more complex architecture with larger effective hydrophobic volume and potentially different surface properties, enabling improved penetration across biological barriers and enhanced bioavailability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly improves the bioavailability of hydrophobic drugs by increasing the drug transfer across biological barriers by an order of magnitude and achieving higher drug encapsulation levels compared to conventional block copolymers, with molar drug encapsulation ratios up to 1:67, enhancing the delivery of poorly soluble drugs.
Implementation Method 1
amphiphilic carbohydrate polymers are capable of self assembling to form micellar clusters in which the carbohydrate amphiphiles aggregate into hierarchically organised micellar clusters of individual aggregates
Implementation Method 2
the combination of both polar and apolar segments in a molecule allows the manipulation of immiscible liquids
Implementation Method 3
Micellar phases have been used to solubilise drugs in aqueous media
Data Source
Figure 1~2a
Figure 2b~2c
Figure 2d~3a
AI summary
Polymeric micellar clusters formed from amphiphilic carbohydrate polymers and their uses in formulating drugs is disclosed, and in particular the finding that amphiphilic carbohydrate polymers are capable of self assembling to form micellar clusters in which the carbohydrate amphiphiles aggregate into hierarchically organised micellar clusters of individual aggregates. The micellar clusters may be transformed into stable nanoparticles with drugs, especially hydrophobic drugs that have poor aqueous solubility, and may improve the transfer of hydrophobic drugs across biological barriers.
